Swedish Orphan Biovitrum Balance Sheet Health
Financial Health criteria checks 3/6
Swedish Orphan Biovitrum has a total shareholder equity of SEK37.1B and total debt of SEK17.5B, which brings its debt-to-equity ratio to 47.1%. Its total assets and total liabilities are SEK72.2B and SEK35.1B respectively. Swedish Orphan Biovitrum's EBIT is SEK6.1B making its interest coverage ratio 4.5. It has cash and short-term investments of SEK594.0M.
Key information
47.1%
Debt to equity ratio
SEK 17.47b
Debt
| Interest coverage ratio | 4.5x |
| Cash | SEK 594.00m |
| Equity | SEK 37.11b |
| Total liabilities | SEK 35.09b |
| Total assets | SEK 72.20b |
Recent financial health updates
Swedish Orphan Biovitrum (STO:SOBI) Has A Pretty Healthy Balance Sheet
Jan 21
Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Jun 24Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Recent updates
Swedish Orphan Biovitrum (STO:SOBI) Has A Pretty Healthy Balance Sheet
Jan 21Earnings Tell The Story For Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Dec 30Swedish Orphan Biovitrum AB (publ) Just Beat EPS By 95%: Here's What Analysts Think Will Happen Next
Oct 27Earnings Beat: Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jul 19Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Jun 24Here's Why Shareholders May Consider Paying Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) CEO A Little More
May 08Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 27Investors Still Waiting For A Pull Back In Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Apr 24Swedish Orphan Biovitrum AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 06Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Swedish Orphan Biovitrum's (STO:SOBI) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 15Financial Position Analysis
Short Term Liabilities: SOBI's short term assets (SEK12.6B) do not cover its short term liabilities (SEK13.9B).
Long Term Liabilities: SOBI's short term assets (SEK12.6B) do not cover its long term liabilities (SEK21.2B).
Debt to Equity History and Analysis
Debt Level: SOBI's net debt to equity ratio (45.5%) is considered high.
Reducing Debt: SOBI's debt to equity ratio has reduced from 55.4% to 47.1% over the past 5 years.
Debt Coverage: SOBI's debt is well covered by operating cash flow (38.1%).
Interest Coverage: SOBI's interest payments on its debt are well covered by EBIT (4.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/03 08:33 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Swedish Orphan Biovitrum AB (publ) is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Shirley Chen | Barclays |
| Rosie Turner | Barclays |